Free Trial
NASDAQ:NH

NantHealth (NH) Stock Price, News & Analysis

NantHealth logo
$0.01 0.00 (0.00%)
As of 07/28/2025

About NantHealth Stock (NASDAQ:NH)

Key Stats

Today's Range
$0.0120
$0.0120
50-Day Range
$0.0030
$0.0130
52-Week Range
$1.24
$9.75
Volume
3 shs
Average Volume
38,073 shs
Market Capitalization
$92.44 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

New Hampshire House Results 2024
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
New Hampshire Governor Results: Kellye Ayotte Wins
25 Fun Things to Do in New Hampshire in 2024
Best High Schools in New Hampshire
See More Headlines

NH Stock Analysis - Frequently Asked Questions

NantHealth's stock was trading at $0.0031 at the start of the year. Since then, NH shares have increased by 287.1% and is now trading at $0.0120.

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.02. The business had revenue of $14.36 million for the quarter, compared to the consensus estimate of $17.70 million.

NantHealth (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Gilead Sciences (GILD).

Company Calendar

Last Earnings
11/04/2021
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Data processing & preparation
Sub-Industry
Business Services
Current Symbol
NASDAQ:NH
Previous Symbol
NYSE:NH
CIK
1566469
Fax
N/A
Employees
340
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($7.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$67.78 million
Net Margins
-94.67%
Pretax Margin
-95.06%
Return on Equity
N/A
Return on Assets
-39.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.64
Quick Ratio
0.64

Sales & Book Value

Annual Sales
$67.68 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($30.72) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
7,703,000
Free Float
2,981,000
Market Cap
$92.44 thousand
Optionable
Not Optionable
Beta
1.82

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NH) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners